ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
2,1,Paraneoplastic pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
3,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
3,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
4,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
5,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5,2,Headache,Headaches NEC,Headaches,Nerv,N
5,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6,4,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
8,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
10,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
12,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
12,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
12,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
12,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
13,1,Blast cell count increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
13,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
13,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
13,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
13,5,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
13,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
13,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
13,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
14,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
15,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,4,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
15,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
16,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
16,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
17,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
18,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
18,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
19,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
20,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
23,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
24,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
24,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
25,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
25,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
25,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
25,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
26,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
27,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
27,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
27,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
27,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
28,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
28,2,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
29,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
30,1,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
30,3,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
31,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
31,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
34,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
35,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
35,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
35,4,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
35,5,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
35,6,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
35,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
35,8,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
36,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
37,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
37,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
38,1,Anogenital dysplasia,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
38,2,Cervix carcinoma stage III,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
38,3,Granuloma,Inflammations,General system disorders NEC,Genrl,N
38,4,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
38,5,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
38,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
38,7,Oophorectomy bilateral,Ovarian therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
38,8,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
38,9,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
38,10,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
38,11,Vulvar dysplasia,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
39,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
40,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
40,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
40,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
40,5,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
40,6,Left ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
40,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
40,8,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
41,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
42,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
42,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
43,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
43,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
44,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
44,3,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
44,4,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
44,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
45,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
46,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
48,1,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
48,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
48,3,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
48,4,Headache,Headaches NEC,Headaches,Nerv,N
48,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
49,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
49,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
49,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
50,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
50,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
51,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
51,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
51,3,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
52,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
52,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
53,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
53,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
53,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
53,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
54,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
54,2,Basal ganglia haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
54,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
54,4,Gastrointestinal angiodysplasia,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
54,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
55,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
56,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
58,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
59,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
60,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
61,1,Abdominal symptom,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
61,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
61,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
61,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
61,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
61,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
61,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
62,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
62,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
62,3,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
63,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
63,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
63,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
63,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
64,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
65,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
66,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
66,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
67,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
67,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
67,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
67,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
67,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
68,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
68,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
69,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
69,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
70,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,2,Headache,Headaches NEC,Headaches,Nerv,N
70,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
72,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
72,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
72,4,Migraine,Migraine headaches,Headaches,Nerv,N
72,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
72,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
72,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
74,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
75,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
75,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
75,4,Therapeutic product effect prolonged,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
77,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
77,2,Total lung capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
77,3,Transfer factor reduced,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
78,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
78,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
79,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
80,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
81,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
82,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
82,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,7,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
83,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
83,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
83,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
83,4,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
83,5,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
83,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
83,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
83,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
83,9,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
83,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
83,12,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
84,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
85,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
85,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
85,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
86,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
86,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
87,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
88,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
89,1,Hydrocele,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
89,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
89,3,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
89,4,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
90,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
91,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
91,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
91,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
92,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
92,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
93,2,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,3,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
94,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
95,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
95,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
96,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
96,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
96,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
96,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
96,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,1,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
98,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
98,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
98,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
98,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
98,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
99,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
100,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
101,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
101,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
101,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
101,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
102,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
102,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
103,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
103,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
103,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
103,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
104,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
104,2,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,3,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
104,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
104,5,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
104,6,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
105,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
106,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
106,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
107,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
107,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
107,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
107,5,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
107,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
107,7,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
107,8,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
107,9,Spleen palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
108,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
109,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
109,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
110,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
110,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
110,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
110,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
110,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
110,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
110,8,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
110,9,Rectal discharge,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
110,10,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
110,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
111,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
111,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
111,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
111,4,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
111,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
111,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
111,7,Myocardial rupture,Myocardial disorders NEC,Myocardial disorders,Card,Y
111,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,9,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
111,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
112,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
112,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
113,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
114,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
115,1,Headache,Headaches NEC,Headaches,Nerv,N
115,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
116,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
117,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
119,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
119,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
120,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
120,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
120,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
120,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
121,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
122,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
123,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
123,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
124,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
125,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
125,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
125,3,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
125,4,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
126,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
127,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
127,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
128,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
129,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
129,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
131,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
131,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
132,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
133,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
134,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
134,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
134,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
134,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
134,5,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
135,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
135,2,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
135,3,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
135,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
135,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
135,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
136,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
136,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
136,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
137,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
137,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
138,1,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
139,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
140,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
140,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
140,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
141,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
141,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
141,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
142,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
143,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
143,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,4,Headache,Headaches NEC,Headaches,Nerv,N
143,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
144,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
144,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
145,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
146,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
146,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
146,4,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
146,5,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
147,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
147,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
147,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
148,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
148,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
148,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
148,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
148,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
149,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
150,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
150,2,IVth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
151,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
151,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
151,3,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
152,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
153,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
153,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
155,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
155,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
155,3,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
155,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
155,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
155,6,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
156,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
156,2,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
156,3,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
156,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
157,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
157,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
157,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
158,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
158,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
158,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
158,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
159,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
160,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
160,2,Arterial occlusive disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
160,3,Arterial stenosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
161,1,Arterial occlusive disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
161,2,Peripheral artery stenosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
162,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
162,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
162,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
162,4,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
162,5,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
162,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
162,7,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
162,8,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
163,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
165,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,2,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
166,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
166,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
167,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
168,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
168,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
169,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
170,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
171,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
171,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
171,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
171,5,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
171,6,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
171,7,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
171,8,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
172,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
172,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
172,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
172,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
172,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
172,6,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
172,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
172,8,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
172,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
172,10,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
172,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
172,12,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
172,13,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
172,14,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
172,15,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
172,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
172,17,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
172,18,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
172,19,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
174,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
175,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
176,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
177,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
177,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
178,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
178,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
179,1,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
180,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
180,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,3,Peripheral artery stenosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
180,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
180,5,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
181,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,Y
181,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
181,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
181,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
181,5,Vascular occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
181,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
182,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
183,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
183,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
183,3,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
184,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
184,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
185,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
185,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
186,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
187,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
187,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
187,3,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
188,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
189,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
190,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
190,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
190,3,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
191,1,Amaurosis fugax,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
191,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
191,3,Carotid artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
192,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
192,2,Peripheral artery stenosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
192,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
192,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
193,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
194,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
194,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
194,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
194,4,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
194,5,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
195,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
196,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
196,2,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
196,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
196,4,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
197,1,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
197,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
198,1,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
199,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
200,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
201,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
201,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
201,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
201,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
202,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
202,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
203,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
204,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
205,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
205,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
205,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
206,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
206,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
207,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
207,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
207,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
207,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
207,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
209,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
210,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
211,2,Anti-neutrophil cytoplasmic antibody positive vasculitis,Vasculitides,Immune disorders NEC,Immun,N
211,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
211,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
211,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
211,6,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
211,7,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
211,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
212,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
213,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
213,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
213,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
213,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
214,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
214,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
214,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
214,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
215,1,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
215,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
216,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
216,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
216,3,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
216,4,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
216,5,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
216,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
216,7,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
216,8,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
217,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
217,2,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
217,3,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
217,4,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
217,5,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
217,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
217,7,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
217,8,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
217,9,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
217,10,Hypercoagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
217,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
217,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,13,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
217,14,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
217,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
218,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
219,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
219,2,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
220,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
220,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
221,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
221,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
222,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
223,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
223,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
223,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
223,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
223,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
225,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
226,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
227,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
228,1,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
229,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
229,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
230,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
230,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
230,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
230,4,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
230,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
230,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
231,1,Central nervous system inflammation,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
231,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
231,3,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
231,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
231,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
231,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
231,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
232,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
233,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
233,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
233,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
235,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
235,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
235,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
235,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
235,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
235,6,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
235,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
235,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
235,9,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
236,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
237,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
237,2,Headache,Headaches NEC,Headaches,Nerv,N
237,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
237,4,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
238,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
238,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
238,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
238,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
238,5,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
238,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
238,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
239,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
239,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
240,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
241,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
241,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
241,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
242,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
243,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
243,2,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
244,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
245,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
246,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
246,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
246,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
246,4,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
246,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
246,6,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
246,7,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
247,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
248,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
248,2,Xanthelasma,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
249,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
250,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
250,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
250,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
250,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
250,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
250,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
250,8,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
251,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
251,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
251,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
251,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
252,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
252,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
252,3,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
252,4,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
252,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
252,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
252,7,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
252,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
252,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
252,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
252,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
253,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
253,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
254,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
255,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
255,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
256,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
256,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
257,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
257,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
258,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
258,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
259,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
260,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
260,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
260,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
262,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
262,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
262,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
263,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
263,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
263,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
263,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
263,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
264,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
264,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
264,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
264,4,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
264,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
264,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
264,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
266,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
267,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
268,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
269,1,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
270,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
270,2,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
271,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
272,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
272,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
273,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
274,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
274,2,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
274,3,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
275,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
276,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
276,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
276,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
276,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
277,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
277,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
277,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
278,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
278,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
279,1,Acne,Acnes,Skin appendage conditions,Skin,N
279,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
279,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
279,4,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
279,5,Oral mucosal discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
279,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
280,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
281,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
282,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
282,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
282,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
283,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
283,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
283,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
283,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
283,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
283,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
284,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
285,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
285,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
286,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
287,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
288,1,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
289,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
290,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
291,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
291,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
292,1,Meibomian gland dysfunction,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
292,2,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
292,3,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
293,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
293,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
293,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
293,4,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
295,1,Retinopathy proliferative,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
295,2,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
296,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
296,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
297,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
298,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
299,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
300,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
300,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
301,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
302,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
303,1,Arterial stenosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
303,2,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
304,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
308,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
308,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
310,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
311,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
311,2,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
312,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
313,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
314,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
315,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
315,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
316,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
316,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
316,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
317,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
317,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
318,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
318,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
318,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
318,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
318,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
319,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
319,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
319,3,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
319,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
319,5,Ehlers-Danlos syndrome,Connective tissue disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
319,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
319,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,8,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
320,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
320,2,Migraine,Migraine headaches,Headaches,Nerv,N
320,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
321,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
323,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
324,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
325,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
325,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
325,3,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
325,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
325,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
325,6,Migraine,Migraine headaches,Headaches,Nerv,N
325,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,8,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
325,9,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
325,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
325,11,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,12,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
325,13,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
325,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
326,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
327,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
327,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
327,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
328,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
328,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
328,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
328,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
329,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
332,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
332,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
332,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
332,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
333,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
333,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
333,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
333,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
334,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
334,2,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
335,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
336,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
336,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
337,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
337,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
338,1,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
339,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
340,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
340,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
340,3,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
340,4,Glomerulosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
341,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
341,2,Platelet maturation arrest,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
341,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
341,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
341,5,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
342,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
342,2,T-cell prolymphocytic leukaemia,Leukaemias chronic T-cell,Leukaemias,Neopl,N
343,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
343,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
344,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
345,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
345,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
347,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
347,2,Blood bilirubin decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
347,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
347,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
347,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
348,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
348,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
348,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
349,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
350,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
350,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
351,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
352,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
352,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
352,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
353,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
354,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
354,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
354,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
355,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
355,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
356,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,2,Hyperamylasaemia,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
356,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
356,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
357,2,Hyperamylasaemia,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
357,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
358,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
358,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
359,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
359,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
359,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
360,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
360,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
360,4,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
360,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
360,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
360,7,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,8,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
360,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
360,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
360,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
360,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
360,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
360,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
360,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
360,16,Shift to the left,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
360,17,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,18,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,19,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
361,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
362,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
363,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
364,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
364,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
365,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
365,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
365,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
365,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
365,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
365,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
365,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
365,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
365,9,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
365,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
365,11,Spirometry abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
365,12,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
366,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
366,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
366,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
367,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
368,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
368,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
368,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
368,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
368,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
369,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
369,2,Rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
370,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
370,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
370,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
371,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
371,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
372,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
372,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
372,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
373,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
373,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
373,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
373,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
375,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
376,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
376,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
376,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
376,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
377,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,3,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
377,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
377,5,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
377,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
378,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
378,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
378,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
378,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
378,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
379,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
379,5,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
379,6,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
380,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
380,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
380,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
381,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
381,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
381,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
382,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
383,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
383,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
384,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,3,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
384,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
385,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
385,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
385,4,Headache,Headaches NEC,Headaches,Nerv,N
385,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
385,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
386,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
387,1,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
388,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
389,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
389,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
390,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
391,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
392,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
392,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
392,4,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,5,Pleuroparenchymal fibroelastosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
393,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
393,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
394,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
395,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
396,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
396,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
396,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
398,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
398,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
399,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
400,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
400,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
400,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
400,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
400,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
401,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
401,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
403,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
404,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
406,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
406,4,Vascular insufficiency,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
407,1,Salivary gland disorder,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
408,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
409,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
409,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
410,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
411,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
411,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
412,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
415,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
415,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
415,3,Headache,Headaches NEC,Headaches,Nerv,N
416,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
416,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
416,4,Effusion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
417,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
417,3,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
417,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
417,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
418,2,Keratosis pilaris,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
418,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
419,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
419,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
419,3,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
420,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
420,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
420,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
420,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
420,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
420,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
421,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
421,2,Headache,Headaches NEC,Headaches,Nerv,N
421,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
421,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
421,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
422,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
423,1,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
423,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
424,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
424,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,2,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
426,1,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
426,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
427,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
428,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,2,Headache,Headaches NEC,Headaches,Nerv,N
429,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
429,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
430,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
430,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
430,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
430,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
430,5,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
430,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
430,7,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
431,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
431,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
432,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
432,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
433,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
434,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
434,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
434,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
435,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
436,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
436,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
436,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
436,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
436,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
436,6,Headache,Headaches NEC,Headaches,Nerv,N
436,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
436,8,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
437,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
437,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
438,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
438,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
438,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
439,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
440,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
441,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
442,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
442,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
443,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
445,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
445,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
446,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
446,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
447,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
447,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
447,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
448,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
449,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
449,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
449,5,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
449,6,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
449,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
449,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
450,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
450,2,Aortic dilatation,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
450,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
450,4,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
450,5,Hypertrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
450,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
451,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
451,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
451,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
452,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
452,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
453,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
453,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
453,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,4,Headache,Headaches NEC,Headaches,Nerv,N
453,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
453,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
453,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
453,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
453,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
453,10,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
454,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
454,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
455,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
456,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
457,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
457,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
457,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
457,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
457,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
457,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
458,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
458,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
458,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
458,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
458,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
459,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
459,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
459,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
459,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
460,1,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
460,2,Chronic myeloid leukaemia transformation,Leukaemias chronic myeloid,Leukaemias,Neopl,N
461,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
461,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
463,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
464,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
467,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
467,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
469,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
470,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
470,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
471,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
471,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
471,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
471,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
471,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
472,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
472,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
473,1,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
474,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
474,2,Tyrosine kinase mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
475,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
476,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
476,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
476,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
477,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
477,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
477,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
477,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
478,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
478,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
479,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
479,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
479,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
479,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
479,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
480,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
480,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
480,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
480,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
480,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
480,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,8,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
481,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
481,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
481,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
482,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
483,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
483,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
483,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
483,5,Headache,Headaches NEC,Headaches,Nerv,N
483,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
483,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
483,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
484,1,Headache,Headaches NEC,Headaches,Nerv,N
485,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
485,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
485,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
485,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
486,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
486,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
486,3,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
487,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
487,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
487,3,Headache,Headaches NEC,Headaches,Nerv,N
487,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
487,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
488,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
488,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
489,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
489,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
489,3,Gene mutation identification test positive,Gene analyses,Cytogenetic investigations and genetic analyses,Inv,N
489,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
489,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
489,6,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
490,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
491,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
492,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
492,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
492,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
493,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
494,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
495,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
495,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
495,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
497,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
498,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
498,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
499,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
499,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
499,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
500,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
501,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
501,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
501,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
501,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
501,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
501,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
501,7,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
501,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
501,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
501,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
502,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
502,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
502,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
503,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
504,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
504,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
504,3,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
504,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
504,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
